Weller K, Groffik A, Magerl M, Tohme N, Martus P, Krause K, Metz M, Staubach P, Maurer M
Always check your insurance covers this treatment and that youre working within your scope of practice
It is an analogue of Growth Hormone Releasing Hormone (GHRH), i.e., it behaves exactly like normally-occurring hormones that your body would produce to stimulate the release of growth hormone
These findings suggest ipamorelin improves delayed gastric emptying by directly enhancing gastric motility through neural activation
A phase 3, randomised, double-blind, parallel-group, event-driven, cardiovascular safety study with BI 456906 administered subcutaneously compared with placebo in participants with overweight or obesity with established cardiovascular disease (CVD) or chronic kidney disease, and/or at least two weight-related complications or risk factors for CVD